Literature DB >> 29355525

Negative regulation of BRCA1 by transforming acidic coiled-coil protein 3 (TACC3).

Jung-Lye Kim1, Geun-Hyoung Ha1, Loredana Campo1, Eun-Kyoung Breuer2.   

Abstract

In spite of the push to identify modifiers of BRCAness, it still remains unclear how tumor suppressor BRCA1 is lost in breast cancers in the absence of genetic or epigenetic aberrations. Mounting evidence indicates that the transforming acidic coiled-coil 3 (TACC3) plays an important role in the centrosome-microtubule network during mitosis and gene expression, and that deregulation of TACC3 is associated with breast cancer. However, the molecular mechanisms by which TACC3 contributes to breast cancer development have yet to be elucidated. Herein, we found that high levels of TACC3 in human mammary epithelial cells can cause genomic instability possibly in part through destabilizing BRCA1. We also found that high levels of TACC3 inhibited the interaction between BRCA1 and BARD1, thus subsequently allowing the BARD1-uncoupled BRCA1 to be destabilized by ubiquitin-mediated proteosomal pathway. Moreover, there is an inverse correlation between TACC3 and BRCA1 expression in breast cancer tissues. Overall, our findings provide a new insight into the role of TACC3 in genomic instability and breast tumorigenesis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BARD1; BRCA1; DNA damage response; Genomic instability; Protein stability; TACC3

Mesh:

Substances:

Year:  2018        PMID: 29355525     DOI: 10.1016/j.bbrc.2018.01.101

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  SIRT2 promotes BRCA1-BARD1 heterodimerization through deacetylation.

Authors:  Elizabeth V Minten; Priya Kapoor-Vazirani; Chunyang Li; Hui Zhang; Kamakshi Balakrishnan; David S Yu
Journal:  Cell Rep       Date:  2021-03-30       Impact factor: 9.423

2.  Mutations in exon region of BRCA1-related RING domain 1 gene and risk of breast cancer.

Authors:  Jun Wu; Alibiati Aini; Binlin Ma
Journal:  Mol Genet Genomic Med       Date:  2022-01-27       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.